Cargando…

Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)

BACKGROUND: Current guidelines from the European Society of Cardiology (ESC) define low thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol (LDL-C) to guide treatment. Although being mainly a prevention tool, its thresholds are difficult to meet in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinhagen-Thiessen, Elisabeth, Bramlage, Peter, Lösch, Christian, Hauner, Hans, Schunkert, Heribert, Vogt, Anja, Wasem, Jürgen, Jöckel, Karl-Heinz, Moebus, Susanne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572156/
https://www.ncbi.nlm.nih.gov/pubmed/18922160
http://dx.doi.org/10.1186/1475-2840-7-31
_version_ 1782160245542354944
author Steinhagen-Thiessen, Elisabeth
Bramlage, Peter
Lösch, Christian
Hauner, Hans
Schunkert, Heribert
Vogt, Anja
Wasem, Jürgen
Jöckel, Karl-Heinz
Moebus, Susanne
author_facet Steinhagen-Thiessen, Elisabeth
Bramlage, Peter
Lösch, Christian
Hauner, Hans
Schunkert, Heribert
Vogt, Anja
Wasem, Jürgen
Jöckel, Karl-Heinz
Moebus, Susanne
author_sort Steinhagen-Thiessen, Elisabeth
collection PubMed
description BACKGROUND: Current guidelines from the European Society of Cardiology (ESC) define low thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol (LDL-C) to guide treatment. Although being mainly a prevention tool, its thresholds are difficult to meet in clinical practice, especially primary care. METHODS: In a nationwide study with 1,511 primary care physicians and 35,869 patients we determined the prevalence of dyslipidemia, its recognition, treatment, and control rates. Diagnosis of dyslipidemia was based on TC and LDL-C. Basic descriptive statistics and prevalence rate ratios, as well as 95% confidence intervals were calculated. RESULTS: Dyslipidemia was highly frequent in primary care (76% overall). 48.6% of male and 39.9% of female patients with dyslipidemia was diagnosed by the physicians. Life style intervention did however control dyslipidemia in about 10% of patients only. A higher proportion (34.1% of male and 26.7% female) was controlled when receiving pharmacotherapy. The chance to be diagnosed and subsequently controlled using pharmacotherapy was higher in male (PRR 1.15; 95%CI 1.12–1.17), in patients with concomitant cardiovascular risk factors, in patients with hypertension (PRR 1.20; 95%CI 1.05–1.37) and cardiovascular disease (PRR 1.46; 95%CI 1.29–1.64), previous myocardial infarction (PRR 1.32; 95%CI 1.19–1.47), and if patients knew to be hypertensive (PRR 1.18; 95%CI 1.04–1.34) or knew about their prior myocardial infarction (PRR 1.17; 95%CI 1.23–1.53). CONCLUSION: Thresholds of the ESC seem to be difficult to meet. A simple call for more aggressive treatment or higher patient compliance is apparently not enough to enhance the proportion of controlled patients. A shift towards a multifactorial treatment considering lifestyle interventions and pharmacotherapy to reduce weight and lipids may be the only way in a population where just to be normal is certainly not ideal.
format Text
id pubmed-2572156
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25721562008-10-24 Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS) Steinhagen-Thiessen, Elisabeth Bramlage, Peter Lösch, Christian Hauner, Hans Schunkert, Heribert Vogt, Anja Wasem, Jürgen Jöckel, Karl-Heinz Moebus, Susanne Cardiovasc Diabetol Original Investigation BACKGROUND: Current guidelines from the European Society of Cardiology (ESC) define low thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol (LDL-C) to guide treatment. Although being mainly a prevention tool, its thresholds are difficult to meet in clinical practice, especially primary care. METHODS: In a nationwide study with 1,511 primary care physicians and 35,869 patients we determined the prevalence of dyslipidemia, its recognition, treatment, and control rates. Diagnosis of dyslipidemia was based on TC and LDL-C. Basic descriptive statistics and prevalence rate ratios, as well as 95% confidence intervals were calculated. RESULTS: Dyslipidemia was highly frequent in primary care (76% overall). 48.6% of male and 39.9% of female patients with dyslipidemia was diagnosed by the physicians. Life style intervention did however control dyslipidemia in about 10% of patients only. A higher proportion (34.1% of male and 26.7% female) was controlled when receiving pharmacotherapy. The chance to be diagnosed and subsequently controlled using pharmacotherapy was higher in male (PRR 1.15; 95%CI 1.12–1.17), in patients with concomitant cardiovascular risk factors, in patients with hypertension (PRR 1.20; 95%CI 1.05–1.37) and cardiovascular disease (PRR 1.46; 95%CI 1.29–1.64), previous myocardial infarction (PRR 1.32; 95%CI 1.19–1.47), and if patients knew to be hypertensive (PRR 1.18; 95%CI 1.04–1.34) or knew about their prior myocardial infarction (PRR 1.17; 95%CI 1.23–1.53). CONCLUSION: Thresholds of the ESC seem to be difficult to meet. A simple call for more aggressive treatment or higher patient compliance is apparently not enough to enhance the proportion of controlled patients. A shift towards a multifactorial treatment considering lifestyle interventions and pharmacotherapy to reduce weight and lipids may be the only way in a population where just to be normal is certainly not ideal. BioMed Central 2008-10-15 /pmc/articles/PMC2572156/ /pubmed/18922160 http://dx.doi.org/10.1186/1475-2840-7-31 Text en Copyright © 2008 Steinhagen-Thiessen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Steinhagen-Thiessen, Elisabeth
Bramlage, Peter
Lösch, Christian
Hauner, Hans
Schunkert, Heribert
Vogt, Anja
Wasem, Jürgen
Jöckel, Karl-Heinz
Moebus, Susanne
Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
title Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_full Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_fullStr Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_full_unstemmed Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_short Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_sort dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the german metabolic and cardiovascular risk project (gemcas)
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572156/
https://www.ncbi.nlm.nih.gov/pubmed/18922160
http://dx.doi.org/10.1186/1475-2840-7-31
work_keys_str_mv AT steinhagenthiessenelisabeth dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas
AT bramlagepeter dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas
AT loschchristian dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas
AT haunerhans dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas
AT schunkertheribert dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas
AT vogtanja dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas
AT wasemjurgen dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas
AT jockelkarlheinz dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas
AT moebussusanne dyslipidemiainprimarycareprevalencerecognitiontreatmentandcontroldatafromthegermanmetabolicandcardiovascularriskprojectgemcas